Kurtz Ronald M MD — SEC Form 4 filings
SEC reporting owner CIK 1295469. 9 Form 4 filings on record with FilingPulse; latest filed 2026-09-09.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-01-09 to 2026-09-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 3 filings — 107,600 shares, $5,206,999 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: sale of 40,000 shares @ $60.15 ($2,405,872) in RxSight, Inc., filed 2024-05-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RxSight, Inc. (RXST) | Chief Medical Officer | 9 | — | 4 legs · 107,600 sh · $5,206,999 | 19 |
Form 4 filings — Kurtz Ronald M MD
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-09 | 4 | RxSight, Inc. (RXST) | Disposition to issuer (D): 338,819 (derivative) · Disposition to issuer (D): 200,000 (derivative) · Disposition to issuer (D): 149,000 (derivative) · Disposition to issuer (D): 215,000 (derivative) · Grant/award (A): 254,751 (derivative) · Grant/award (A): 173,913 (derivative) · +2 more | EDGAR |
| 2026-09-02 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 13,425 · Sale (S): 5,100 @ $6.96 · Option exercise (M): 13,425 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | RxSight, Inc. (RXST) | Grant/award (A): 80,545 (derivative) @ $0 | EDGAR |
| 2025-02-27 | 4 | RxSight, Inc. (RXST) | Grant/award (A): 215,000 (derivative) @ $0 | EDGAR |
| 2024-08-09 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 7,650 @ $15.08 · Option exercise (M): 2,300 @ $4.34 · Option exercise (M): 7,650 (derivative) @ $0 · Option exercise (M): 2,300 (derivative) @ $0 | EDGAR |
| 2024-07-12 | 4 | RxSight, Inc. (RXST) | Option exercise (M): 13,500 @ $15.08 · Option exercise (M): 13,500 (derivative) @ $0 | EDGAR |
| 2024-05-06 | 4 | RxSight, Inc. (RXST) | Sale (S): 40,000 @ $60.15 | EDGAR |
| 2024-03-06 | 4 | RxSight, Inc. (RXST) | Grant/award (A): 149,000 (derivative) @ $0 | EDGAR |
| 2024-01-09 | 4 | RxSight, Inc. (RXST) | Sale (S): 31,250 @ $43.50 · Sale (S): 31,250 @ $45.00 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1295469 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →